MDPI and ACS Style
Luxenburger, A.; Clemmens, H.; Hastings, C.; Harris, L.D.; Ure, E.M.; Cameron, S.A.; Aasly, J.; Bandmann, O.; Weymouth-Wilson, A.; Furneaux, R.H.;
et al. 3α,7-Dihydroxy-14(13→12)abeo-5β,12α(H),13β(H)-cholan-24-oic Acids Display Neuroprotective Properties in Common Forms of Parkinson’s Disease. Biomolecules 2023, 13, 76.
https://doi.org/10.3390/biom13010076
AMA Style
Luxenburger A, Clemmens H, Hastings C, Harris LD, Ure EM, Cameron SA, Aasly J, Bandmann O, Weymouth-Wilson A, Furneaux RH,
et al. 3α,7-Dihydroxy-14(13→12)abeo-5β,12α(H),13β(H)-cholan-24-oic Acids Display Neuroprotective Properties in Common Forms of Parkinson’s Disease. Biomolecules. 2023; 13(1):76.
https://doi.org/10.3390/biom13010076
Chicago/Turabian Style
Luxenburger, Andreas, Hannah Clemmens, Christopher Hastings, Lawrence D. Harris, Elizabeth M. Ure, Scott A. Cameron, Jan Aasly, Oliver Bandmann, Alex Weymouth-Wilson, Richard H. Furneaux,
and et al. 2023. "3α,7-Dihydroxy-14(13→12)abeo-5β,12α(H),13β(H)-cholan-24-oic Acids Display Neuroprotective Properties in Common Forms of Parkinson’s Disease" Biomolecules 13, no. 1: 76.
https://doi.org/10.3390/biom13010076